Madrid, Spain – 30 August 2025: Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no beta-blocker therapy in ...
Beta’s 2026 Evo 300 4T keeps the four-stroke trials formula alive while making the sport more accessible to new riders.
Madrid, Spain – 30 August 2025: Beta-blocker therapy showed no evidence of an effect on all-cause death, reinfarction or heart failure admission in patients with myocardial infarction (MI) managed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results